Effects of the 21-aminosteroid, U74389F, on bleomycin-induced pulmonary fibrosis in rats

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Objective: To determine if a new class of agents, the 21-aminosteroids, which are reportedly potent inhibitors of iron-dependent lipid peroxidation, could protect rats from bleomycin-induced pulmonary fibrosis. Subjects: Fifty-five adult male Sprague-Dawley rats. Design: Prospective, randomized, blinded, controlled trial. Interventions: The rats were subjected to intratracheal bleomycin (or saline vehicle), and were then treated with the 21-aminosteroid, U74389F (20 mg/kg/day), or vehicle, for the next 7 days. Measurements and Main Results: At 21 days after bleomycin administration, pulmonary fibrosis was assessed histologically as percent of lung fields with evidence of fibrosis. Pulmonary fibrosis was assessed biochemically by measuring pulmonary elastin and hydroxyproline content. To determine if a protective effect of U74389F was linked to the 21-aminosteroid's ability to suppress lipid peroxidation, two products of lipid peroxidation were assayed in the lungs at 7 and 14 days after bleomycin exposure. By histologic assessment, the 21-aminosteroid-treated, bleomycin-exposed animals were found to have significantly decreased the extent of pulmonary fibrosis when compared with the bleomycin control group (mean 48.6 ± 20.0 [SD] % [n = 9] vs. 68.4 ± 19.6% [n = 11]; p < .05). In addition, lung elastin was decreased by ~75% (p < .05) and hydroxyproline was decreased by ~50% (NS) in the 21- aminosteroid-treated group when compared with the bleomycin control group. At 7 and 14 days after bleomycin exposure, all bleomycin-exposed animals had evidence of increased lipid peroxidation (conjugated dienes and thiobarbituric acid-reactive substances), but the 21-aminosteroid-treated, bleomycin-exposed animals had significantly decreased evidence of lipid peroxidation when compared with bleomycin controls. Conclusions: The 21- aminosteroid can substantially protect animals from bleomycin-induced pulmonary fibrosis and may prove useful in other lung diseases where iron- dependent, free-radical reactions and/or lipid peroxidation are presumed mechanisms of toxicity.

Original languageEnglish
Pages (from-to)313-319
Number of pages7
JournalCritical Care Medicine
Volume22
Issue number2
StatePublished - Jan 1 1994

Fingerprint

Pulmonary Fibrosis
Bleomycin
Lipid Peroxidation
Lung
Elastin
Hydroxyproline
U 74389F
Iron
Control Groups
Thiobarbituric Acid Reactive Substances
Lung Diseases
Free Radicals
Sprague Dawley Rats
Fibrosis
Randomized Controlled Trials

Keywords

  • bleomycin
  • cardiopulmonary emergencies
  • critical illness
  • iron chelation
  • lipid peroxidation
  • lung injury
  • lungs
  • malondialdehyde
  • oxygen radicals
  • pulmonary fibrosis
  • respiratory failure

ASJC Scopus subject areas

  • Critical Care and Intensive Care Medicine

Cite this

Effects of the 21-aminosteroid, U74389F, on bleomycin-induced pulmonary fibrosis in rats. / McLaughlin, Gwenn E; Frank, L.

In: Critical Care Medicine, Vol. 22, No. 2, 01.01.1994, p. 313-319.

Research output: Contribution to journalArticle

@article{707dd29f369046d7933fdffbab4f8b5a,
title = "Effects of the 21-aminosteroid, U74389F, on bleomycin-induced pulmonary fibrosis in rats",
abstract = "Objective: To determine if a new class of agents, the 21-aminosteroids, which are reportedly potent inhibitors of iron-dependent lipid peroxidation, could protect rats from bleomycin-induced pulmonary fibrosis. Subjects: Fifty-five adult male Sprague-Dawley rats. Design: Prospective, randomized, blinded, controlled trial. Interventions: The rats were subjected to intratracheal bleomycin (or saline vehicle), and were then treated with the 21-aminosteroid, U74389F (20 mg/kg/day), or vehicle, for the next 7 days. Measurements and Main Results: At 21 days after bleomycin administration, pulmonary fibrosis was assessed histologically as percent of lung fields with evidence of fibrosis. Pulmonary fibrosis was assessed biochemically by measuring pulmonary elastin and hydroxyproline content. To determine if a protective effect of U74389F was linked to the 21-aminosteroid's ability to suppress lipid peroxidation, two products of lipid peroxidation were assayed in the lungs at 7 and 14 days after bleomycin exposure. By histologic assessment, the 21-aminosteroid-treated, bleomycin-exposed animals were found to have significantly decreased the extent of pulmonary fibrosis when compared with the bleomycin control group (mean 48.6 ± 20.0 [SD] {\%} [n = 9] vs. 68.4 ± 19.6{\%} [n = 11]; p < .05). In addition, lung elastin was decreased by ~75{\%} (p < .05) and hydroxyproline was decreased by ~50{\%} (NS) in the 21- aminosteroid-treated group when compared with the bleomycin control group. At 7 and 14 days after bleomycin exposure, all bleomycin-exposed animals had evidence of increased lipid peroxidation (conjugated dienes and thiobarbituric acid-reactive substances), but the 21-aminosteroid-treated, bleomycin-exposed animals had significantly decreased evidence of lipid peroxidation when compared with bleomycin controls. Conclusions: The 21- aminosteroid can substantially protect animals from bleomycin-induced pulmonary fibrosis and may prove useful in other lung diseases where iron- dependent, free-radical reactions and/or lipid peroxidation are presumed mechanisms of toxicity.",
keywords = "bleomycin, cardiopulmonary emergencies, critical illness, iron chelation, lipid peroxidation, lung injury, lungs, malondialdehyde, oxygen radicals, pulmonary fibrosis, respiratory failure",
author = "McLaughlin, {Gwenn E} and L. Frank",
year = "1994",
month = "1",
day = "1",
language = "English",
volume = "22",
pages = "313--319",
journal = "Critical Care Medicine",
issn = "0090-3493",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Effects of the 21-aminosteroid, U74389F, on bleomycin-induced pulmonary fibrosis in rats

AU - McLaughlin, Gwenn E

AU - Frank, L.

PY - 1994/1/1

Y1 - 1994/1/1

N2 - Objective: To determine if a new class of agents, the 21-aminosteroids, which are reportedly potent inhibitors of iron-dependent lipid peroxidation, could protect rats from bleomycin-induced pulmonary fibrosis. Subjects: Fifty-five adult male Sprague-Dawley rats. Design: Prospective, randomized, blinded, controlled trial. Interventions: The rats were subjected to intratracheal bleomycin (or saline vehicle), and were then treated with the 21-aminosteroid, U74389F (20 mg/kg/day), or vehicle, for the next 7 days. Measurements and Main Results: At 21 days after bleomycin administration, pulmonary fibrosis was assessed histologically as percent of lung fields with evidence of fibrosis. Pulmonary fibrosis was assessed biochemically by measuring pulmonary elastin and hydroxyproline content. To determine if a protective effect of U74389F was linked to the 21-aminosteroid's ability to suppress lipid peroxidation, two products of lipid peroxidation were assayed in the lungs at 7 and 14 days after bleomycin exposure. By histologic assessment, the 21-aminosteroid-treated, bleomycin-exposed animals were found to have significantly decreased the extent of pulmonary fibrosis when compared with the bleomycin control group (mean 48.6 ± 20.0 [SD] % [n = 9] vs. 68.4 ± 19.6% [n = 11]; p < .05). In addition, lung elastin was decreased by ~75% (p < .05) and hydroxyproline was decreased by ~50% (NS) in the 21- aminosteroid-treated group when compared with the bleomycin control group. At 7 and 14 days after bleomycin exposure, all bleomycin-exposed animals had evidence of increased lipid peroxidation (conjugated dienes and thiobarbituric acid-reactive substances), but the 21-aminosteroid-treated, bleomycin-exposed animals had significantly decreased evidence of lipid peroxidation when compared with bleomycin controls. Conclusions: The 21- aminosteroid can substantially protect animals from bleomycin-induced pulmonary fibrosis and may prove useful in other lung diseases where iron- dependent, free-radical reactions and/or lipid peroxidation are presumed mechanisms of toxicity.

AB - Objective: To determine if a new class of agents, the 21-aminosteroids, which are reportedly potent inhibitors of iron-dependent lipid peroxidation, could protect rats from bleomycin-induced pulmonary fibrosis. Subjects: Fifty-five adult male Sprague-Dawley rats. Design: Prospective, randomized, blinded, controlled trial. Interventions: The rats were subjected to intratracheal bleomycin (or saline vehicle), and were then treated with the 21-aminosteroid, U74389F (20 mg/kg/day), or vehicle, for the next 7 days. Measurements and Main Results: At 21 days after bleomycin administration, pulmonary fibrosis was assessed histologically as percent of lung fields with evidence of fibrosis. Pulmonary fibrosis was assessed biochemically by measuring pulmonary elastin and hydroxyproline content. To determine if a protective effect of U74389F was linked to the 21-aminosteroid's ability to suppress lipid peroxidation, two products of lipid peroxidation were assayed in the lungs at 7 and 14 days after bleomycin exposure. By histologic assessment, the 21-aminosteroid-treated, bleomycin-exposed animals were found to have significantly decreased the extent of pulmonary fibrosis when compared with the bleomycin control group (mean 48.6 ± 20.0 [SD] % [n = 9] vs. 68.4 ± 19.6% [n = 11]; p < .05). In addition, lung elastin was decreased by ~75% (p < .05) and hydroxyproline was decreased by ~50% (NS) in the 21- aminosteroid-treated group when compared with the bleomycin control group. At 7 and 14 days after bleomycin exposure, all bleomycin-exposed animals had evidence of increased lipid peroxidation (conjugated dienes and thiobarbituric acid-reactive substances), but the 21-aminosteroid-treated, bleomycin-exposed animals had significantly decreased evidence of lipid peroxidation when compared with bleomycin controls. Conclusions: The 21- aminosteroid can substantially protect animals from bleomycin-induced pulmonary fibrosis and may prove useful in other lung diseases where iron- dependent, free-radical reactions and/or lipid peroxidation are presumed mechanisms of toxicity.

KW - bleomycin

KW - cardiopulmonary emergencies

KW - critical illness

KW - iron chelation

KW - lipid peroxidation

KW - lung injury

KW - lungs

KW - malondialdehyde

KW - oxygen radicals

KW - pulmonary fibrosis

KW - respiratory failure

UR - http://www.scopus.com/inward/record.url?scp=0028107170&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028107170&partnerID=8YFLogxK

M3 - Article

C2 - 7508358

AN - SCOPUS:0028107170

VL - 22

SP - 313

EP - 319

JO - Critical Care Medicine

JF - Critical Care Medicine

SN - 0090-3493

IS - 2

ER -